Related Experiment Videos
Human chondrocyte senescence and osteoarthritis
James A Martin1, Joseph A Buckwalter
1University of Iowa Department of Orthopaedic Surgery, Iowa City, IA 52242, USA.
Biorheology
|June 26, 2002
Summary
Aging increases osteoarthritis risk as cartilage cells senesce, losing their ability to maintain tissue. This cellular aging, marked by increased beta-galactosidase and shorter telomeres, explains age-related cartilage decline and OA incidence.
Area of Science:
- Biogerontology
- Orthopedics
- Cellular Biology
Background:
- Osteoarthritis (OA) incidence strongly correlates with age, though aging itself doesn't guarantee OA development.
- Articular cartilage health relies on chondrocytes' ability to maintain the extracellular matrix.
- Age-related changes in chondrocytes are suspected contributors to OA pathogenesis.
Purpose of the Study:
- To investigate the role of chondrocyte senescence in the age-related increase of osteoarthritis.
- To determine if cellular aging markers in chondrocytes correlate with donor age.
Main Methods:
- Assessed senescence markers in human articular cartilage chondrocytes from 27 donors (ages 1-87).
- Measured beta-galactosidase expression, mitotic activity (3H-thymidine incorporation), and telomere length.
- Correlated these markers with donor age.
Main Results:
- Beta-galactosidase expression significantly increased with age (r=0.84, p=0.0001).
- Mitotic activity and mean telomere length significantly declined with age (r=-0.774, p=0.001 and r=-0.71, p=0.0004).
- Shorter telomeres correlated with higher beta-galactosidase and lower mitotic activity.
Conclusions:
- In vivo articular cartilage chondrocyte senescence contributes to age-related OA incidence.
- Individual OA risk may vary based on the onset of chondrocyte senescence.
- Senescence may limit the efficacy of chondrocyte transplantation in older individuals.
- Strategies targeting chondrocyte senescence could prevent or slow OA progression.